On February 2, 2023, Global Pharma Healthcare, at the FDA’s recommendation, issued a voluntary nationwide recall of EzriCare® Artificial Tears and Delsam Pharma® Artificial Tears Lubricant Eye Drops due to suspected bacterial contamination. By May 2023, the CDC reported 81 infections in 18 states, including 14 patients with vision loss, four who required surgical removal of an eye, and four deaths. Affected individuals and families may be eligible to pursue compensation.